Transvivo Incorporated

Transvivo's SCIPTM System was acclaimed as a "revolutionary" new development in therapeutic apheresis during the 2004 Joint Meeting of the World and American Societies for Apheresis. Clinical trials have begun with the plasmapheresis catheter which continuously filters blood inside the body for a hemodynamically-stable therapeutic alternative to intermittent blood purification therapies such as plasma exchange, dialysis or artificial organ support. Transvivo received FDA approval in 2004 to begin clinical investigation in Congestive Heart Failure patients.

Contact Details: 1100 Lincoln Ave., Suite 108 Napa California 94558 United States of America Tel: (707) 254-9597 Fax: (707) 254-9599 Email: hhandley@transvivo.com WWW: www.transvivo.com/

Loading...

Recent Publications by Transvivo Incorporated:
Slow continuous intravenous plasmapheresis (SCIP): clinical applications and hemostability of extracorporeal ultrafiltration. An intravenous plasmapheresis catheter which excludes >99.4% of platelets...	29th June, 2005	Transvivo,	Contrib Nephrol. 2005;149:334-42. DOI Direct Link
Artificial in vivo biofiltration: slow continuous intravenous plasmafiltration (SCIP) and artificial organ support. An intravenous plasmafiltration (SCIP) catheter has been developed and is...	23rd July, 2004	Transvivo,	Int J Artif Organs. 2004 Mar;27(3):186-94.
An experimental temporary vascular access catheter for intracorporeal plasma separation. An intravenous plasmafiltration (SCIP) catheter has been developed and is...	10th February, 2004	Transvivo,	Contrib Nephrol. 2004;142:376-86.
Slow continuous intracorporeal plasmapheresis for acute fluid overload. Intermittent dialysis is still the predominant treatment for acute or...	7th November, 2003	Transvivo,	Blood Purif. 2003;21(1):72-8. DOI Direct Link
Intravenous catheter for intracorporeal plasma filtration. Future advances in dialysis of end-stage renal disease patients may...	5th April, 2003	Transvivo,	Blood Purif. 2002;20(1):61-9.
→View more Transvivo Incorporated research publications.

Transvivo Incorporated Patents:
US Patent No.	Title
7585412	Specialized hollow fiber membranes for plasmapheresis and ultrafiltration
5980481	Method and apparatus for continuous peritoneal cascade dialysis and hemofiltration (CPCD/H)
6234991	Method and apparatus for continuous peritoneal cascade dialysis and hemofiltration (CPCD/H)
6561996	Apparatus and method for in vivo hemodialysis
6607501	Process and apparatus for utilization of in vivo extracted plasma with tissue engineering devices, bioreactors, artificial organs, and cell therapy applications
→View more Transvivo Incorporated patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 580 times since April 2007, the link to the organisation's website has been followed 117 times

Recent Search Terms used to find this page: transvivo fda | transvivo fda | transvivo | Transvivo | transvivo | transvivo | Transvivo | Transvivo | transvivo | transvivo | .

Search for more companies in Napa

Search for more companies in California

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Transvivo Incorporated